Clinical TrialID 7955

Oropharyngeal Immunoprophylaxis With High Polyphenolic Olive Oil as Clinical Spectrum Mitigating Factor in COVID-19.

NCT05685901

COVID-19

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7955
Evidence Id
7955
Core Evidence Id
7955
Source Clinical Trial Id
7951
Herb2 Clinical Trial Id
HBCT007951
Nct Id
NCT05685901
Title
Oropharyngeal Immunoprophylaxis With High Polyphenolic Olive Oil as Clinical Spectrum Mitigating Factor in COVID-19.
Status
Completed
Phase
Study Result
No
Study Condition
COVID-19
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION
Intervention
DIETARY_SUPPLEMENT: High polyphenolic olive oil. (Early harvest olive oil).
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Triple
Intervention Purpose
Prevention
Gender
All
Age
Adult, Older_Adult
Enrollment
88
Outcome Measure
Incidence., High polyphenolic olive oil immunoprophylaxis intervention and incidence of COVID-19., 3 months.
Sponsor Collaborator
Hospital General Nuestra Señora del Prado
Funded By
OTHER
Location
Hospital Nuestra Señora del Prado, Talavera de la Reina., Toledo, 45600, Spain
Other Id
OLEOCOVID
Start Date
2021-07-01
Primary Completion Date
2022-09-30
Completion Date
2022-09-30
First Posted
2023-01-17
Results First Posted
Last Update Posted
2023-01-17
Study Document
Study Protocol, Statistical Analysis Plan, and Informed Consent Form, https://cdn.clinicaltrials.gov/large-docs/01/NCT05685901/Prot_SAP_ICF_000.pdf
Study Url
https://clinicaltrials.gov/study/NCT05685901
Title Cn
Title En
Oropharyngeal Immunoprophylaxis With High Polyphenolic Olive Oil as Clinical Spectrum Mitigating Factor in COVID-19.
Bilingual Status
semi_complete